cymedics cryo

  • 2 big and 2 small applicators for individual use
  • No personnel needed during the application
  • Individual setting of customer parameters
  • Gentle application because of vacuum modulation
  • Automatic safety and shut-off
  • Separately controllable applicators
  • Automatic safety- / shut-off system
  • Application temperature from +2°C to -10°C programmable
  • Low maintenance device with very low consumables costs
  • Ideal combination with cymedics premium and cymedics avita+
  • Only consumables needed: the inexpensive antifreeze membrane

Ice-cold beauty
Literally, a truly cool thing: cymedics cryo uses the methodology
and technology of controlled cryolipolysis for use on stubborn fat deposits. The outstanding advantage of this non-invasive procedure is in its high degree of efficiency and extremely low time requirement.
Thanks to the fully automated application and monitoring, minimize your time-related personnel costs and benefit from a uniquely favourable cost-benefit ratio. Not only this, but your customers will also be highly satisfied. After all, just one to up to a maximum of three treatments per area are necessary. These can be repeated on the same site every six to eight weeks.


Model : cymedics cryo
Lowest cooling temperature : –10°C
Programmable time : 30 –80 minutes (deviation ± 5%)
Max. vacuum pressure : – 250 mbar
Vacuum setting range : –100 mbar to –250 mbar (tolerance ±10%)
Power connector : 220 -240 VAC / 50-60Hz
Cooling : Destilled and deioized water
Dimensions (W x D x H) : 73 cm x 61 cm x 127 cm
Weight : approx. 55 kg
Equipment class : Class I, Type BF
Protection class : IP10

  • Clinical Efficacy of Noninvasive Cryolipolysis and Its Effects on Peripheral Nerves
    by Sydney R. Coleman, Kulveen Sachdeva, Barbara M. Egbert, Jessica Preciado, John Allison
  • Cryolipolysis: A Historical Perspective and Current Clinical Practice
    By H. Ray Jalian, MD, and Mathew M. Avram, MD, JD
  • Cryolipolysis for Reduction of Excess Adipose Tissue
    By Andrew A. Nelson, MD,* Daniel Wasserman, MD,† and Mathew M. Avram, MD, JD‡